Balchem (BCPC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 18, 2025, at 6:15 PM EDT, with virtual attendance available.
Shareholders are encouraged to review proxy materials and vote by June 17, 2025, or June 13, 2025, for 401(k) plan shares.
Voting matters and shareholder proposals
Election of three directors: Theodore L. Harris, Monica Vicente, and Matthew Wineinger, all recommended for approval.
Ratification of RSM US LLP as independent registered public accounting firm for fiscal year 2025.
Advisory vote on executive compensation for Named Executive Officers, recommended for approval.
Proxies may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Balchem
- Record sales, earnings, and cash flow growth, with increased dividends and strong global expansion.BCPC
Q4 202520 Feb 2026 - Record Q2 earnings and margin gains led by Human Nutrition & Health and Specialty Products.BCPC
Q2 20242 Feb 2026 - Q3 2024 net earnings rose 16.4% on 4.3% higher sales, led by Human Nutrition & Health.BCPC
Q3 202418 Jan 2026 - Record Q1 sales, double-digit profit growth, and margin expansion across all segments.BCPC
Q1 202524 Dec 2025 - Record sales, profit, and cash flow growth, with strong innovation and sustainability progress.BCPC
Q4 20249 Dec 2025 - Record financials, sustainability gains, and strong governance drive all Board-backed proposals.BCPC
Proxy Filing1 Dec 2025 - Optimizing energy and amino acid profiles boosts nitrogen efficiency and sustainability.BCPC
Status Update23 Nov 2025 - Record sales, margin expansion, and strategic investments drive robust Q2 growth and outlook.BCPC
Q2 202516 Nov 2025 - Record Q3 2025 sales and earnings growth, strong cash flow, and positive outlook maintained.BCPC
Q3 202522 Oct 2025